Login / Signup

Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles.

Aditi MehtaElena Dalle VedoveLorenz IsertOlivia M Merkel
Published in: Pharmaceutical research (2019)
BSA nanoparticles loaded with mutant specific siRNA are a promising therapeutic approach for KRAS-mutant cancers.
Keyphrases
  • wild type
  • cancer therapy
  • drug delivery
  • wound healing
  • young adults